Floatz logo

12 assets in Diffuse Large B-Cell Lymphoma Of The Central Nervous System

Therapeutic assets addressing Diffuse Large B-Cell Lymphoma Of The Central Nervous System, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Nivolumab
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P2B (60)
Dexasone
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (47)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P2CC (44)
Diphenhydramine
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Ibrutinib
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Lenalidomide
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Methotrexate
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Obinutuzumab
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Pegfilgrastim
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Prednisone
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Rituximab
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Venetoclax
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)